Surgical treatment of intravenous leiomyomatosis with intracardial growth in conditions of artificial circulation. Clinical case
https://doi.org/10.17650/2782-3202-2024-4-1-58-62
Abstract
Intravenous leiomyomatosis is a smooth muscle tumor of unclear malignant potential capable of intravascular growth with varying levels of intravascular advancement. The only radical treatment method is surgical intervention requiring quality preoperative preparation and determination of optimal surgical tactics taking into account the level of damage. A description of a clinical case of intravenous leiomyomatosis with intracardial growth is presented
About the Authors
M. M. DavydovRussian Federation
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
A. A. Filatov
Russian Federation
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
E. V. Glukhov
Russian Federation
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
Z. M. Cheishvilli
Russian Federation
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
V. E. Gruzdev
Russian Federation
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
E. A. Fomina
Russian Federation
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
References
1. Gynecology: textbook. Ed. by G.M. Savelyeva, V.G. Breusenko. Moscow: GEOTAR-Media, 2008. P. 268. (In Russ.).
2. World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs. Ed. by F.A. Tavassoli, P. Devilee. Lyon: IARC Press, 2003. Pp. 218–242.
3. Lim W.H., Lamaro V.P., Sivagnanam V. Manifestation and management of intravenous leiomyomatosis: a systematic review of the literature. Surg Oncol 2022;45:101879. DOI: 10.1016/j.suronc.2022.101879
4. Clement P.B. Intravenous leiomyomatosis of the uterus. Pathology Annu 1988;23 Pt 2:153–83
Review
For citations:
Davydov M.M., Filatov A.A., Glukhov E.V., Cheishvilli Z.M., Gruzdev V.E., Fomina E.A. Surgical treatment of intravenous leiomyomatosis with intracardial growth in conditions of artificial circulation. Clinical case. MD-Onco. 2024;4(1):58-62. (In Russ.) https://doi.org/10.17650/2782-3202-2024-4-1-58-62